Elevance Health ELV Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.76B-19.4% | $546M+32.2% | $1.19B+17.8% | $1.74B-24.2% | $2.18B-2.9% | ||
| $354M-5.1% | $406M+2.0% | $387M+17.6% | $380M+13.4% | $373M+12.7% | ||
| $55M-32.1% | $30M— | $84M+27.3% | $81M-12.0% | $81M+30.6% | ||
| -$274M-57.5% | -$322M-178% | $269M+220% | -$52M+69.4% | -$174M-228% | ||
| —— | $30M— | —— | —— | —— | ||
| $1.17B-63.0% | —— | —— | $923M-12.8% | $3.17B+1,026% | ||
| $4.33B+326% | $84M-88.1% | $1.14B-57.6% | $2.05B+360% | $1.02B-48.6% | ||
| $235M+19.9% | $293M-9.0% | $360M+8.4% | $267M-17.3% | $196M-29.7% | ||
| -$5M-25.0% | -$33M-101% | -$1M— | -$50M-1,350% | -$4M-100% | ||
| $4.74B+19.5% | $2.76B-15.8% | $4.16B-10.9% | $4.14B+5.2% | $3.96B-35.0% | ||
| -$1.64B-1,694% | —— | -$1.22B-205% | -$687M+16.0% | $103M+104% | ||
| $376M-2.6% | $377M+1.1% | $376M-2.6% | $385M+1.9% | $386M+1.8% | ||
| $1.12B+27.7% | $471M-74.0% | $876M+1,360% | $378M-18.4% | $880M+55.5% | ||
| —— | —— | $2.99B— | —— | —— | ||
| $750M-40.0% | —— | $900M+12.5% | —— | $1.25B— | ||
| $37M+60.9% | —— | —— | —— | $23M-76.3% | ||
| $34M-72.4% | $1M-66.7% | —— | —— | $123M+23.0% | ||
| -$2.52B-31.7% | —— | —— | -$308M-146% | -$1.91B-6,066% | ||
| -$9M-1,000% | -$6M+25.0% | -$1M-114% | $1M+120% | $1M— | ||
| $166M+121% | $778M+66.2% | $153M-88.8% | $1.06B+263% | -$788M-163% | ||
| $4M— | $38M+47.6% | —— | —— | $0-100% | ||
| $305M+142% | $147M+819% | $113M— | $12M— | $126M+567% | ||
| $2.89B+203% | -$2.26B-88.3% | -$151M-124% | $738M+32.5% | $952M+470% | ||
| $266M+102% | -$338M+33.1% | $270M-13.5% | -$79M-1,088% | $132M+83.3% | ||
| $644M+80.4% | -$284M-264% | -$616M-1,181% | $246M— | $357M-38.6% | ||
| $1.55B+140% | -$460M+73.8% | —— | —— | $647M-41.4% | ||
| -$78M+83.2% | -$57M+23.0% | -$1M+99.2% | -$131M-54.1% | -$464M-188% | ||
| $313M+7.9% | —— | $110M+168% | $176M+61.5% | $290M+36.8% | ||
| $10M-60.0% | -$52M-286% | $14M-54.8% | $13M-63.9% | $25M-13.8% | ||
| $552M+30.2% | $576M+5.9% | $447M+0.4% | $324M-35.3% | $424M-20.7% | ||
| $3.09B-25.4% | $2.67B-46.0% | $2.98B-26.1% | $3.53B+31.5% | $4.15B-15.3% | ||
| -$1.15B-311% | $1.24B+365% | —— | $85M— | $546M+193% | ||
| $313M+7.9% | —— | $110M+168% | $176M+63.0% | $290M+36.8% | ||
| -$3M+78.6% | $12M— | $21M+2,000% | $3M-25.0% | -$14M-450% | ||
| $724M— | $515M+692% | —— | —— | $0-100% | ||
| —— | $19.75M-64.3% | $19.75M-64.3% | $19.75M-64.3% | $19.75M-64.3% | ||
| $150M+30.4% | $545M+808% | $1.17B+1,460% | $0— | $115M— | ||
| $1.59B+165% | $1.1B+4,032% | -$1.26B-183% | —— | $600M+1,835% | ||
| $4.1B+399% | $0-100% | $775M-67.0% | $1.79B+1,341% | $821M-51.7% | ||
| $4.1B+399% | $0-100% | $775M-67.0% | $1.79B+1,341% | $821M-51.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Elevance Health generate?
- Elevance Health (ELV) generated $7.6B in operating cash flow over the trailing twelve months.
- What is Elevance Health's free cash flow?
- After $1.2B of capital expenditures, Elevance Health's free cash flow was $6.7B over the trailing twelve months, up 81.3% year over year.
- Where does Elevance Health's cash flow data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
